Funding round
LifeMine Series D
LifeMine, which works in top-down drug discovery services in Cambridge, raised $75M in a Series D round announced on 6 Aug 2026, led by Milky Way Investments. 6 firms took part. It is LifeMine's fifth venture round on record; the one before was a Series C in Mar 2022.
$75M
Amount raised
Not disclosed
Post-money valuation
6
Investors
1 lead
Valuation
What this round says about the price
LifeMine did not disclose a valuation in this round. It came 53 months after LifeMine's Series C. It is 12% of the $623M LifeMine has raised in the venture rounds on record. LifeMine raised again: a Series E round of $263M in Aug 2026.
LifeMine's funding rounds
LifeMine has 6 venture rounds on record. This one is highlighted.
- Seed 12 Jan 2016, led by WuXi Healthcare Ventures $5.0M
- Series A 18 Sep 2017, led by WuXi Healthcare Ventures $55M
- Series B 8 Jan 2021, led by Milky Way Investments $50M
- Series C 23 Mar 2022, led by Fidelity Management & Research Company $175M
- Series D this round 6 Aug 2026, led by Milky Way Investments $75M
- Series E 7 Aug 2026, led by Milky Way Investments $263M
Investors
Who put money in
Milky Way Investments led the round with 5 other firms.
Lead investor
- Milky Way Investments new investor
Also in the round
- Bezos Expeditions new investor
- Gates Frontier new investor
- backs 109 venture-backed companies new investor
- LoLa Capital Partners new investor
- Confidential investor new investor
Use of proceeds
What the money is for
According to the announcement, the money goes to product development, scaling operations and working capital.
- Product development
- Scaling operations
- Working capital
Comparable rounds
How it compares
5 Series D rounds in Biotechnology within a year either side disclosed an amount; the median was $150M, and this round was 50% of the median. The closest in time, other companies' Series D rounds in Biotechnology:
| Company | Announced | Amount | Post-money | Led by |
|---|---|---|---|---|
| Biotechnology | 6 May 2026 | $220M | not disclosed | Venrock |
| Biotechnology | 8 Apr 2026 | $80M | not disclosed | not named |
| Kriya Therapeutics Biotechnology | 10 Sep 2025 | $320M | not disclosed | Patient Square Capital and Premji Invest |
| Enveda Biotechnology | 4 Sep 2025 | $150M | not disclosed | Premji Invest |
| Biotechnology | 30 Sep 2025 | $125M | not disclosed | Sanofi Ventures and Viking Global |
Sources
Where this comes from
Reported by 2 sources. The deal data marks this round as not yet confirmed by an official announcement. Unconfirmed
Questions
Frequently asked
How much did LifeMine raise in its Series D round?
LifeMine raised $75M in its Series D round, announced in Aug 2026.
Who led LifeMine's Series D round?
Milky Way Investments led it, with Bezos Expeditions, Gates Frontier, RA Capital, LoLa Capital Partners and Confidential investor.
What was LifeMine's valuation at the Series D round?
It was not disclosed.
How does it compare with other Series D rounds in Biotechnology?
5 Series D rounds in Biotechnology within a year either side disclosed an amount; the median was $150M, and this round was 50% of the median.
Did LifeMine raise again after this round?
Yes: a Series E round in Aug 2026 of $263M.